awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38963970-68E2F883-E6C5-429B-840D-4A7CC8C7B4E2
Q38963970-68E2F883-E6C5-429B-840D-4A7CC8C7B4E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38963970-68E2F883-E6C5-429B-840D-4A7CC8C7B4E2
The design of clinical trials to support the switching and alternation of biosimilars.
P2860
Q38963970-68E2F883-E6C5-429B-840D-4A7CC8C7B4E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38963970-68E2F883-E6C5-429B-840D-4A7CC8C7B4E2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ddb1331dad432e9ee2aac55b372ee6f8d7e4ab4b
P2860
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study.